Tianyuan Qiu , Zengguang Liu , Hugang Zhang , Jiaxin Jia , Xinxin Shao , Sihan Wang , Haobo Han , Quanshun Li , Min Hu
{"title":"Engineered exosomes with enriched miR-23b suppress the progression of periodontitis by reprogramming macrophages","authors":"Tianyuan Qiu , Zengguang Liu , Hugang Zhang , Jiaxin Jia , Xinxin Shao , Sihan Wang , Haobo Han , Quanshun Li , Min Hu","doi":"10.1016/j.colsurfb.2025.114947","DOIUrl":null,"url":null,"abstract":"<div><div>Periodontitis is a prevalent inflammatory disease that damages the tooth-supporting structure, leading to tooth instability and loss. Conventional therapies target biofilms but fail to address immune dysregulation, highlighting the need of host-modulating strategies. Herein, the decreased miR-23b level was found to be associated with the progression of periodontitis and identified as a potential therapeutic agent for the disease. Since the conventional methods of loading exogenous miRNAs into exosomes may impair the membrane structure, a miR-23b-overexpressed HEK293T cell line was constructed to produce engineered exosomes with enriched miR-23b (namely miR-23b-Exo). The miR-23b-Exo modulated the NF-κB signaling pathway in macrophages, thereby promoting the M2 polarization and suppressing the release of inflammatory cytokines to execute the anti-inflammatory effect. In rats with periodontitis, miR-23b-Exo alleviated the inflammation-induced periodontal damage, exhibiting favorable anti-periodontitis efficacy. Our study provides a promising host-modulating strategy based on the engineered exosomes-mediated miR-23b delivery, thereby alleviating periodontal damage by reprogramming macrophages.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"255 ","pages":"Article 114947"},"PeriodicalIF":5.4000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525004540","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Periodontitis is a prevalent inflammatory disease that damages the tooth-supporting structure, leading to tooth instability and loss. Conventional therapies target biofilms but fail to address immune dysregulation, highlighting the need of host-modulating strategies. Herein, the decreased miR-23b level was found to be associated with the progression of periodontitis and identified as a potential therapeutic agent for the disease. Since the conventional methods of loading exogenous miRNAs into exosomes may impair the membrane structure, a miR-23b-overexpressed HEK293T cell line was constructed to produce engineered exosomes with enriched miR-23b (namely miR-23b-Exo). The miR-23b-Exo modulated the NF-κB signaling pathway in macrophages, thereby promoting the M2 polarization and suppressing the release of inflammatory cytokines to execute the anti-inflammatory effect. In rats with periodontitis, miR-23b-Exo alleviated the inflammation-induced periodontal damage, exhibiting favorable anti-periodontitis efficacy. Our study provides a promising host-modulating strategy based on the engineered exosomes-mediated miR-23b delivery, thereby alleviating periodontal damage by reprogramming macrophages.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.